HTB South

Opportunistic infections

High prevalence of COPD at baseline in START study sub-study

Immunotherapy for PML: two case reports using IL-7 and experimental recombinant JCV VP1 protein therapeutic vaccination

Kidney signal trouble worsens over 5 years in Japanese on tenofovir

RIFAQUIN study demonstrates once-weekly dosing during follow-up phase of TB treatment

Combining Xpert and LAM urine testing improves TB diagnostic sensitivity

Deferring ART by four weeks reduces mortality in patients diagnosed with cryptococcal meningitis

Case report: homozygous CCR5 delta-32 protection overcome by infection with X4 virus

No association between atazanavir and MI or stroke in D:A:D study

HIV and the brain: longitudinal results from CHARTER and other studies

Systolic blood pressure and risk of myocardial infarction in HIV infection

Risk of non-AIDS defining malignancies and immune suppression

Renal impairment in the D:A:D study

No increased risk of non-AIDS deaths from cumulative use of ART in EuroSIDA cohort

Hearing loss not associated with HIV in MACS and WIHS cohorts

Clinical benefits of stopping smoking: CVD and CHD risk returns to that of ‘previous smoker’ in HIV-positive people within three years

HIV increases the risk of lung cancer, independent of smoking status

BHIVA draft guidelines for the treatment of opportunistic infections: online for comment

Association between inflammation and sleep apnea in the MACS cohort

Smoking masks the long-term benefits of HAART on lung function

Influenza vaccine effective in HIV-positive adults

Results from HSV-2 acyclovir studies

Single high dose fluconazole for oropharyngeal candidiasis (OPC) comparable to standard 14-day treatment